Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia

This publication has 153 references indexed in Scilit:

• Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial
  Nature Medicine, 2007
• Psychosis: Atypical limbic epilepsy versus limbic hyperexcitability with onset at puberty?
  Epilepsy & Behavior, 2007
• The Neuregulin-1 Receptor ErbB4 Controls Glutamatergic Synapse Maturation and Plasticity
  Neuron, 2007
• DTNBP1 genotype influences cognitive decline in schizophrenia
  Schizophrenia Research, 2007
• A Neurobehavioral Systems Analysis of Adult Rats Exposed to Methylazoxymethanol Acetate on E17: Implications for the Neuropathology of Schizophrenia
  Biological Psychiatry, 2006
• Serine racemase binds to PICK1: potential relevance to schizophrenia
  Molecular Psychiatry, 2005
• Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
  Molecular Psychiatry, 2004
• NMDA antagonist effects on striatal dopamine release: Positron emission tomography studies in humans
  Synapse, 2001
• Smoking and Vulnerability for Schizophrenia
  Schizophrenia Bulletin, 1996
• Methylazoxymethanol Treatment of Fetal Rats Results in Abnormally Dense Noradrenergic Innervation of Neocortex
  Science, 1979